- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 02, 2024, 12:18:59 PM
- Local Time:
- May 17, 2024, 10:26:43 AM
- Last Active:
- May 02, 2024, 06:25:29 PM
Signature:
Toripalimab along with pembrolizumab are part of anti-programmed dying receptor-1 monoclonal antibodies for the treatment of various cancers. Anti-pro